Schweiger Dermatology Group Announces $100 Million Investment
Schweiger Dermatology Group , the largest dermatology practice management company in the Northeast with 40 locations, has received an investment of $100 million from LNK Partners, a private equity firm with a long track record of investing in consumer businesses. LNK will hold a minority stake in the company, and Eric Schweiger, MD, founder and CEO, will continue to lead SDG as the company expands its footprint in the Northeast.
“We're excited to partner with Schweiger Dermatology Group,” said David Landau, co-founder of LNK Partners. “Dr. Schweiger founded SDG with the goal of making high-quality dermatology care accessible throughout the metro New York/New Jersey area, and we're proud to partner with the SDG management team to bring Dr. Schweiger's vision to life throughout the entire Northeast.”
This investment from LNK Partners will be used to support SDG's growth as it continues to build new locations and acquire dermatology practices in the current core market of New York and New Jersey as well as...
The last Posts from "Surgical Aesthetics Magazine"
- Thomas Freyman Joins Allergan Board of Directors
- Dermatology Medical Scribe Training Now Available
- Two Things That Reduce Medical Malpractice Claims in Plastic Surgery
- Topical Brimonidine Following IPL Offers Same Efficacy With Less Erythema
- Next Generation Imaging
- Lightweight Sun Protection
- Over The Counter Eczema Care
- Automated Before and Afters
- Total Lip Care
- Handheld Body Imaging System
- CareCredit Expands To Spa Market
- Restoration Robotics Launches Master Class for ARTAS Robotic Hair Restoration
- Canada Approves Thermi RF for Treatment of Dermal Laxity
- Microbotox Versus Nefertiti Lift for Lower Face Rejuvenation
- Practice Management: Extending Care
- Eclipse Announces Its 2018 Medical and Scientific Advisory Board
- InMode Introduces EmbraceRF for Facial Contouring
- Differing Behavior of Facial Fat Compartments
- Newsmakers: Skin of Color Society
- Silvernail Named CFO of Evolus
The headlines of Master Doctor
Clostridium Difficile Infections Decreasing in Canadian Hospitals
Clostridium difficile infections have decreased by 36 percent in Canadian hospitals, although the virulent NAP1 strain associated with severe illness and deaths is the most...
Mother's Diabetes Linked to Increased Autism Risk for Children
Risk of autism spectrum disorder may be increased in children of mothers with the three main types of diabetes that complicate pregnancy. The severity of maternal diabetes and...
Now You Can Put Plasters to Your Mouth Ulcers
Plaster which sticks for mouth ulcers will revolutionize treatment of oral conditions. The patch successfully administers steroids directly to oral ulcers or lesions whilst...
Antiviral Gene Study Offers Novel Approach for Attacking Disease-causing Viruses
Promising platform for new drugs to attack disease-causing viruses has emerged from a study on how antiviral gene works.
Two for one deals on junk food to be banned to tackle obesity crisis
The proposals are expected to be unveiled tomorrow as part of the new Childhood Obesity Strategy, which aims to halve the problem in the UK by 2030.
Blood Test Can Predict Spastic Cerebral Palsy
DNA patterns in circulating blood cells can be used to help identify spastic cerebral palsy patients through a blood test and even predict childhood leukemia show breakthrough...
Starving Fungi Could Save Millions of Lives Each Year, Reveals Research
A potentially new approach to treating lethal fungal infections that claim more than 1.6 million lives each year: starving the fungi of key nutrients, preventing their growth...
Key Step Towards a Computer Model That Predicts the Outcome of Eye Diseases
Newly developed model of the retina can predict with high precision the outcome of a defined perturbation.
The most hilarious memes mocking TIME's fake news "screaming migrant girl...
By now, everybody knows that TIME Magazine's “screaming migrant girl” cover photo is yet another blatant media hoax. The girl, who was falsely described by virtually the entire...
New Device Enables Test for Cancer Drug Combinations on Tumor Biopsies
Miniature testing of drug pairs on tumor biopsies has been enabled by a new microfluidic device that fits in the palm of the hand. The device is the latest advancement in the...